CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa. (2015)

First Author: Lipinski DM
Attributed to:  Developing gene therapy to treat blindness caused by Stargardt Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/mt.2015.68

PubMed Identifier: 25896245

Publication URI: http://europepmc.org/abstract/MED/25896245

Type: Journal Article/Review

Volume: 23

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 8

ISSN: 1525-0016